Comparative Evaluation of Alb PRF Versus Connective Tissue Graft in Reconstruction of Deficient Interdental Papilla
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Albumin (5% serum-protein solution containing immunoglobulins), connective tissue graft.
- Who it may be relevant to
- Registry conditions: Deficient Interdental Papilla. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of Albumin Platelet-Rich Fibrin Versus Subepithelial Connective Tissue Graft in Interdental Papilla Reconstruction: a Randomized Controlled Clinical Trial
Overview
This study will evaluate the efficacy of Alb PRF membrane in comparison to a subepithelial connective tissue graft in the reconstruction of interdental papillae.
Detailed description
the reconstruction will be done using the Hans Taki surgical technique, while Alb PRF will be used as a membrane.
Interventions
- Biological Albumin (5% serum-protein solution containing immunoglobulins)
a variation of PRF done by heating up to 75 degree then mixed with the remaining prf to get membrane - Biological connective tissue graft
subepithelial connective tissue graft
Primary outcome measures
- papillary height measured from apical part of contact point to tip of papilla (CP-TP) [Time frame: from enrollment, 3 months, 6months, 9months, 12months]
Eligibility criteria
Inclusion criteria
- inter dental papilla deficincy
Exclusion criteria
- smokers
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07597135 · Alb-PRF vs connective tissue